<--- Back to Details
First PageDocument Content
Anatomy / Rheumatologists / Geneticists / Peter K. Gregersen / Arthritis / MHC Class II / Rheumatoid arthritis / Autoimmunity / HLA-DR4 / Biology / Medicine / Immunology
Date: 2014-07-02 23:37:45
Anatomy
Rheumatologists
Geneticists
Peter K. Gregersen
Arthritis
MHC Class II
Rheumatoid arthritis
Autoimmunity
HLA-DR4
Biology
Medicine
Immunology

Add to Reading List

Source URL: www.kva.se

Download Document from Source Website

File Size: 1,80 MB

Share Document on Facebook

Similar Documents

Kidney diseases / Autoimmune diseases / Rheumatology / Rheumatologists / Cutaneous lupus erythematosus / Systemic lupus erythematosus / Lupus nephritis / Nephrology / Mycophenolic acid / Medicine / Health / Anatomy

ADVANCES IN RHEUMATOLOGY Affiliated with Columbia University College of Physicians and Surgeons and Weill Cornell Medical College NOVEMBER/DECEMBER 2014 The rheumatology program at NewYorkPresbyterian Hospital is compris

DocID: 1fzzx - View Document

Presentation of Navigare Patient Flow and Positioning Product Group: Biological Drugs Target Groups: Rheumatologists Dermatologists Gastroenterologists Countries:

DocID: 1eAsN - View Document

Developed in Partnership with Rheumatologists Raintree Delivers EMR and Practice Management in a Single Software Solution

DocID: 1d2Up - View Document

Important Safety Information for Rheumatologists About Risks in Patients Receiving ACTEMRA® ACTEMRA® (tocilizumab) is an interleukin-6 (IL-6) receptor antagonist that has been approved by the Food and Drug Administrati

DocID: 1bTad - View Document

Arthritis / Rheumatoid arthritis / Rheumatologists / Rheumatology / Disease-modifying antirheumatic drug / Placebo / Tofacitinib / Anakinra / Medicine / Health / Immunosuppressants

542 CONCISE REPORT Formative research in clinical trial development: attitudes of patients with arthritis in enhancing prevention trials

DocID: 1anTs - View Document